Brain proton magnetic spectroscopy in long-term treatment of Wilson’s disease patients

被引：0
|
作者：
Beata Tarnacka
Wojciech Szeszkowski
Marek Gołębiowski
Anna Członkowska
机构：
[1] Institute of Psychiatry and Neurology,2nd Neurological Department
[2] Warsaw Medical University,II Department of Clinical Radiology
[3] Warsaw Medical University,I Department of Clinical Radiology
[4] Medical Academy,Department of Clinical and Experimental Pharmacology
来源：
Metabolic Brain Disease | 2010年 / 25卷
关键词：
Wilson disease; Magnetic resonance spectroscopy; Treatment;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
We reported the brain proton magnetic resonance spectroscopy (MRS) findings in 27 Wilson’s disease (WD) patients treated more than 6 years in neurological (nWD) and hepatic (hWD) subgroups. We investigated 4 hWD patients, with no improvement and 8 with marked improvement; and 8 nWD patients with marked improvement and 7 with no improvement of clinical status. In nWD patients with improvement the MRS showed significantly higher Cho/Cr, Glx/Cr ratios levels. In hWD patients with no improvement the lower Cho/Cr and in nWD significantly lower NAA/Cr and higher Cho/Cr and Lip/Cr ratios were detected. In nWD patients with improvement the spectroscopic pattern, can be related to gliosis. In patients with no neurological improvement a persistent neuronal dysfunction can occur, perhaps as a result of copper or iron deposition.
引用
收藏
页码：375 / 379
页数：4
相关论文
共 50 条
  • [1] Brain proton magnetic spectroscopy in long-term treatment of Wilson’s disease patients
    Beata Tarnacka
    Wojciech Szeszkowski
    Marek Gołębiowski
    Anna Członkowska
    Metabolic Brain Disease, 2010, 25 : 325 - 329
  • [2] Brain proton magnetic spectroscopy in long-term treatment of Wilson's disease patients
    Tarnacka, Beata
    Szeszkowski, Wojciech
    Golebiowski, Marek
    Czlonkowska, Anna
    METABOLIC BRAIN DISEASE, 2010, 25 (03) : 325 - 329
  • [3] Brain proton magnetic spectroscopy in long-term treatment of Wilson's disease patients
    Tarnacka, Beata
    Szeszkowski, Wojciech
    Golebiowski, Marek
    Czlonkowska, Anna
    METABOLIC BRAIN DISEASE, 2010, 25 (04) : 375 - 379
  • [4] Magnetic resonance proton spectroscopy of the brain in Wilson’s disease
    E. Kraft
    Claudia Trenkwalder
    Florian Then Bergh
    Dorothee P. Auer
    Journal of Neurology, 1999, 246 : 693 - 699
  • [5] Magnetic resonance proton spectroscopy of the brain in Wilson's disease
    Kraft, E
    Trenkwalder, C
    Bergh, FT
    Auer, DP
    JOURNAL OF NEUROLOGY, 1999, 246 (08) : 693 - 699
  • [6] Long-term experience with 110 Wilson's disease patients
    Relja, M.
    Miletic, V.
    MOVEMENT DISORDERS, 2010, 25 (07) : S506 - S506
  • [7] Long-term outcome of patients with Wilson's disease in Serbia
    Tomic, A.
    Svetel, M.
    Pekmezovic, T.
    Kresojevic, N.
    Petrovic, I.
    Spica, V.
    Lukic, M. Jecmenica
    Stojkovic, T.
    Stefanova, E.
    Kostic, V. S.
    MOVEMENT DISORDERS, 2009, 24 : S132 - S132
  • [8] Long-term outcome of patients with Wilson's disease in Serbia
    Svetel, M.
    Pekmezovic, T.
    Petrovic, I.
    Tomic, A.
    Kresojevic, N.
    Spica, V.
    Lukic, M. Jecmenica
    Stojkovic, T.
    Kostic, V.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 191 - 191
  • [9] Hepatic Wilson's disease: Initial treatment and long-term management
    Walshe J.M.
    Current Treatment Options in Gastroenterology, 2005, 8 (6) : 467 - 472
  • [10] Incompliance in long-term treated patients with neurological Wilson's disease
    Samadzadeh, Sara
    Novak, Max
    Kruschel, Theo
    Albrecht, Philipp
    Hartmann, Christian J.
    Meuth, Sven G.
    Hefter, Harald
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 321 - 321
12345